Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China
· Delayed Price · Currency is CNY 13.27
+0.36 (2.79%)
Mar 10, 2026, 10:35 AM CST
Yifan Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 13,384 | 13,040 | 18,014 | 15,019 | 21,745 | 23,372 | Upgrade
|
| Market Cap Growth | 0.48% | -27.61% | 19.94% | -30.93% | -6.96% | 36.83% | Upgrade
|
| Enterprise Value | 14,902 | 14,371 | 19,400 | 16,499 | 22,717 | 23,710 | Upgrade
|
| Last Close Price | 12.91 | 10.63 | 14.52 | 12.03 | 17.31 | 18.55 | Upgrade
|
| PE Ratio | 38.00 | 33.78 | - | 78.54 | 78.11 | 24.14 | Upgrade
|
| Forward PE | 25.31 | 20.82 | 33.59 | 16.33 | 32.78 | 16.68 | Upgrade
|
| PS Ratio | 2.56 | 2.53 | 4.43 | 3.92 | 4.93 | 4.33 | Upgrade
|
| PB Ratio | 1.54 | 1.55 | 2.18 | 1.64 | 2.48 | 2.68 | Upgrade
|
| P/TBV Ratio | 3.06 | 3.29 | 4.67 | 2.82 | 4.23 | 4.70 | Upgrade
|
| P/FCF Ratio | - | 1037.05 | - | - | - | 59.50 | Upgrade
|
| P/OCF Ratio | 21.82 | 20.35 | 51.68 | 31.82 | 72.19 | 21.09 | Upgrade
|
| PEG Ratio | - | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
| EV/Sales Ratio | 2.85 | 2.79 | 4.77 | 4.30 | 5.15 | 4.39 | Upgrade
|
| EV/EBITDA Ratio | 19.16 | 22.36 | 76.48 | 43.52 | 50.06 | 19.91 | Upgrade
|
| EV/EBIT Ratio | 37.43 | 44.07 | 17820.38 | 96.29 | 86.48 | 23.38 | Upgrade
|
| EV/FCF Ratio | -238.51 | 1142.95 | - | - | - | 60.36 | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.27 | 0.24 | 0.24 | 0.26 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 3.24 | 3.49 | 7.34 | 5.44 | 4.84 | 1.39 | Upgrade
|
| Debt / FCF Ratio | - | 182.47 | - | - | - | 4.23 | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.17 | 0.15 | 0.10 | 0.11 | 0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.15 | 2.19 | 4.82 | 2.47 | 2.07 | 0.24 | Upgrade
|
| Net Debt / FCF Ratio | -26.27 | 111.73 | -7.86 | -13.35 | -3.47 | 0.74 | Upgrade
|
| Asset Turnover | 0.41 | 0.43 | 0.34 | 0.31 | 0.37 | 0.48 | Upgrade
|
| Inventory Turnover | 2.36 | 2.83 | 2.45 | 2.65 | 4.16 | 4.91 | Upgrade
|
| Quick Ratio | 0.80 | 0.84 | 0.94 | 1.19 | 1.13 | 1.22 | Upgrade
|
| Current Ratio | 1.27 | 1.26 | 1.49 | 1.68 | 1.56 | 1.65 | Upgrade
|
| Return on Equity (ROE) | 4.39% | 3.88% | -10.18% | 1.42% | 2.77% | 11.25% | Upgrade
|
| Return on Assets (ROA) | 1.95% | 1.71% | 0.01% | 0.87% | 1.38% | 5.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.33% | 2.81% | 0.01% | 1.40% | 2.80% | 10.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.10% | 3.50% | 0.00% | 1.70% | 2.70% | 10.70% | Upgrade
|
| Earnings Yield | 3.04% | 2.96% | -3.06% | 1.27% | 1.28% | 4.14% | Upgrade
|
| FCF Yield | -0.47% | 0.10% | -0.86% | -0.47% | -1.24% | 1.68% | Upgrade
|
| Dividend Yield | 0.75% | 1.88% | - | - | - | 0.27% | Upgrade
|
| Payout Ratio | 42.85% | 50.47% | - | 45.18% | 49.71% | 20.86% | Upgrade
|
| Buyback Yield / Dilution | 1.94% | 1.51% | 3.94% | -5.32% | 1.26% | -0.40% | Upgrade
|
| Total Shareholder Return | 2.69% | 3.39% | 3.94% | -5.32% | 1.26% | -0.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.